Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.51 | 12.58 |
| PEG Ratio (TTM) | 0.88 | 1.13 |
| P/S Ratio (TTM) | 0.73 | 0.78 |
| P/B Ratio (TTM) | 1.40 | 1.17 |
| P/FCF Ratio (TTM) | 10.81 | -0.29 |
| Price to 5YR AVG Earnings Ratio | 10.34 | 7.09 |
| Price to 5YR AVG FCF Ratio | 19.29 | 7.74 |
Profitability (60%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.43% | 6.51% |
| ROE (TTM) | 13.44% | 9.82% |
| Net Profit Margin (TTM) | 6.95% | 6.39% |
| ROIC 5YR AVG | 23.02% | 20.75% |
Growth (68%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -9.31% | 42.36% | 58.80% |
| Revenue | -2.60% | 14.12% | 14.71% |
| Net Income | -9.44% | 43.94% | 59.46% |
| Cash Flow | 7.31% | 630.12% | 437.76% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.24 | 2.70 |
| Quick Ratio (TTM) | 2.83 | 1.55 |
| D/E Ratio (TTM) | 0.28 | 0.36 |
| Interest Coverage (TTM) | 18.16 | 36.54 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 4.41 | 3.61 |
| LTL to 5YR AVG FCF | 3.63 | 2.93 |
| Shares Outstanding Growth 5YR AVG | 0.06% | -3.23% |